The technique should be relatively easy, reproducible, and predictably performed as described.
A provisional, single-stent strategy is currently regarded as the default strategy for the treatment of bifurcation lesions, because of beneficial outcomes associated with this technique (1, 2) . However, this approach cannot be applied broadly across all bifurcation lesions because of the likelihood of side branch (SB) compromise in the presence of high-risk features (e.g. significant SB ostial disease) or because the SB has significant disease extending beyond its ostium requiring treatment (3) . In such circumstances, the high risk of SB occlusion (and resultant periprocedural myocardial infarction) or residual critical stenosis on the SB demand the implementation of a 2-stent strategy in a bid to maintain optimal vessel patency and blood flow in both the main branch (MB) and the SB.
The ostium of the SB is the weakest segment in bifurcation lesions, being the most common location of restenosis (4) . A number of different 2-stent techniques have been described, including T-stenting (5), T and protrusion, crush (6) , and culotte stenting (7), in addition to the development of dedicated bifurcation devices (8) , in an attempt to optimize the immediate and long-term results of the SB following treatment. However, each of these strategies has limitations, including stent distortion, inadequate ostial coverage, and multiple stent layers that contribute to restenosis.
Once the decision has been made to perform a 2-stent strategy, the ideal technique should satisfy the following properties:
Optimal coverage of the SB ostium with no gaps between the MB and SB stent.
Minimal distortion of the SB stent at the ostium of the SB.
Minimal overlap between the MB and SB stents.
Short procedural time.
Minimal requirement of additional guidewires and balloons.
The ability to maintain control of both the MB and the SB so that there is little risk of comprised blood flow in either branch.
The technique should be relatively easy, reproducible, and predictably performed as described.
A guiding catheter no greater than 6-F should be required.
Immediate and long-term clinical results (e.g., target lesion revascularization) should be at least noninferior, if not superior, to existing techniques.
To date, no single approach is able to deliver all of the desired attributes as described. Therefore, the relentless effort to develop a better solution is laudable. Drs. Colombo and Ruparelia have reported that they have no relationships relevant to the contents of this paper to disclose. The wire used to cross the protruding stent strut into the MB may cross outside the SB strut resulting in a mini-crush. 
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